|
|
|
|
|
|
Repros Therapeutics (RPRX)
|
|
0.39 -0.02 (-4.13%)
|
6/23/2017 4:00pm
|
|
Open:
|
0.41
|
Pre. Close:
|
0.41
|
|
High:
|
0.43
|
Low:
|
0.36
|
|
Volume:
|
1,311,139
|
Market Cap:
|
10.43M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.44 - 0.45
|
0.45 - 0.45
|
|
Low:
|
0.34 - 0.35
|
0.35 - 0.35
|
|
Close:
|
0.38 - 0.39
|
0.39 - 0.4
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:38:02 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 0.75 One year: 0.98
|
|
Support:
|
Support1: 0.33 Support2: 0.27
|
|
Resistance:
|
Resistance1:
0.65 Resistance2: 0.84
|
|
Pivot:
|
0.40
|
|
Moving Averages:
|
MA(5): 0.37  MA(20): 0.43
MA(100): 0.96 MA(250): 1.46
|
|
MACD:
|
MACD(12,26):
-0.10 Signal(12,26,9): -0.12
|
|
%K %D:
|
%K(14,3): 31.82 %D(3): 20.94
|
|
RSI:
|
RSI(14): 31.10
|
|
52-Week:
|
High: 2.48
Low: 0.33 Change(%): -77.1
|
|
Average Vol(K):
|
3-Month: 277
10-Days 614
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.RPRX has closed above bottom band by 46.6%. Bollinger Bands are 35% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 23 Jun 2017 18:22:30 GMT
Repros Therapeutics Inc. (RPRX): What's the Story?
Fri, 23 Jun 2017 15:45:00 GMT
Repros Therapeutics Inc. (RPRX) is down on 20 DMA
Mon, 10 Apr 2017 13:19:12 GMT
Repros Names Larry Dillaha, MD, its Permanent President and CEO
Mon, 17 Apr 2017 13:07:30 GMT
Repros Announces the Issuance of New US Patent Relating to Treatment Using Off ...
Thu, 22 Jun 2017 14:03:45 GMT
Active Runner in Focus: Repros Therapeutics Inc (RPRX)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
